Diana Tran
Burlington, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mission impossible? Caveats in interpreting and comparing long-term efficacy in biologic studies for moderate-to-severe plaque psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 29, 2024
Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib.
Journal: Journal of medical economics
Published: July 11, 2023
Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 21, 2022
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States.
Journal: Infectious diseases and therapy
Published: November 22, 2022
Systematic literature review of evidence in amyloid light-chain amyloidosis.
Journal: Journal of comparative effectiveness research
Published: February 21, 2022
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: February 18, 2022
Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP) in Italy.
Journal: PharmacoEconomics - open
Published: June 24, 2021
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 16, 2021
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies.
Journal: European heart journal. Quality of care & clinical outcomes
Published: January 21, 2021
A reply to "Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model".
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 29, 2020
The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.
Journal: Current medical research and opinion
Published: February 04, 2020
Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 22, 2019
Last Updated: 09/26/2026